Rapid Immunity News Today

The study tracks the long-term kinetics of antibody responses to SARS-CoV-2 after vaccination and infections in New York healthcare workers from 2020 to 2023. It reveals that antibody waning is slower after booster shots, but there's an upper limit to antibody levels, which gradually lowers with repeated SARS-CoV-2 exposures and vaccinations.

Researchers assess the durability and effectiveness of immune responses against SARS-CoV-2 in terms of spike-binding antibody titers.

In multiple studies from eight cohorts across the United States, a group of researchers accelerated the collection of essential data to answer questions about the immune response needed for long-term protection against SARSCoV2.

New study decodes important questions on the durability and effectiveness of immune responses against SARS-CoV-2.

By pooling studies from eight cohorts across the United States, a group of researchers accelerated the collection of essential data to answer questions about th

By uniting research from 8 cohorts across the U.S., a group of researchers has accelerated collection of data integral in answering questions about immune responses needed for long lasting protection from SARS-CoV-2.

Researchers discussed the stability of spike antibody titers mounted against SARS-CoV-2 infection, and their ability to protect from infection with antigenically similar variants.

Researchers analyzed sera samples of 400 participants of the PARIS study to evaluate the risk of SARS-CoV-2 infection and seroreversion for an average of 84 days.

Researchers determine the serum neutralizing and binding activity against the SARS-CoV-2 Omicron variant in individuals with different levels of immunity.

Results of a new study show that the induction of anti-SARSCoV-2 spike saliva SIgA antibodies after vaccination is independent of the gender or type of vaccine received.